These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 15982339

  • 1. The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults.
    Harrison P.
    Br J Haematol; 2005 Jul; 130(1):3-10. PubMed ID: 15982339
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. PFA-100 closure times in preoperative screening in 500 pediatric patients.
    Roschitz B, Thaller S, Koestenberger M, Wirnsberger A, Leschnik B, Fritsch P, Muntean W.
    Thromb Haemost; 2007 Jul; 98(1):243-7. PubMed ID: 17598019
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center.
    Ortel TL, James AH, Thames EH, Moore KD, Greenberg CS.
    Thromb Haemost; 2000 Jul; 84(1):93-7. PubMed ID: 10928477
    [Abstract] [Full Text] [Related]

  • 6. The platelet function analyzer (PFA-100): an update on its clinical use.
    Franchini M.
    Clin Lab; 2005 Jul; 51(7-8):367-72. PubMed ID: 16122146
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The utility of the PFA-100 in the identification of von Willebrand disease: a concise review.
    Favaloro EJ.
    Semin Thromb Hemost; 2006 Jul; 32(5):537-45. PubMed ID: 16862528
    [Abstract] [Full Text] [Related]

  • 15. [New in vitro analysis tested: bleeding time is still the best method for evaluation of primary hemostasis].
    Ridefelt P, Egberg N, Hillarp A, Lethagen S, Tengborn L.
    Lakartidningen; 2001 Sep 12; 98(37):3922-4. PubMed ID: 11586831
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.
    Hanebutt FL, Rolf N, Loesel A, Kuhlisch E, Siegert G, Knoefler R.
    Haemophilia; 2008 May 12; 14(3):524-30. PubMed ID: 18284449
    [Abstract] [Full Text] [Related]

  • 19. [Preoperative identification of patients with impaired (primary) haemostasis. A practical concept].
    Koscielny J, Ziemer S, Radtke H, Schmutzler M, Kiesewetter H, Salama A, von Tempelhoff GF.
    Hamostaseologie; 2007 Aug 12; 27(3):177-84. PubMed ID: 17694224
    [Abstract] [Full Text] [Related]

  • 20. A reassessment of the bleeding time: association of age, hematocrit, platelet function, von Willebrand factor, and bleeding time thromboxane B2 with the length of the bleeding time.
    Gerrard JM, Docherty JC, Israels SJ, Cheang MS, Bishop AJ, Kobrinsky NL, Schroeder ML, Israels ED.
    Clin Invest Med; 1989 Jun 12; 12(3):165-71. PubMed ID: 2787219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.